← Back

Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. is an ophthalmic medical company operating in China, Hong Kong, Europe, the United States, and Southeast Asia. It provides diagnosis and treatment of ophthalmic diseases, surgical services, medical optometry, and lens fitting for conditions such as fundus diseases, glaucoma, and cataract. The company also offers training courses covering cataract cases, ICL surgery, and presbyopia surgery. Founded in 2002, it is headquartered in Changsha, China.

Country
Price · split & dividend adjusted
News & notes moving 300015.CS
300015.CS3

Aier Eye Hospital's 2026 interim net profit was 1.357 billion yuan, down 33.83% year-on-year

Aier Eye Hospital released its 2026 interim report. Total operating revenue was 11.946 billion yuan, and net profit attributable to the parent company was 1.357 billion yuan, down 33.83% from the same period last year. Net cash inflow from operating activities was 2.923 billion yuan, down 14.10% year-on-year. The company's asset-liability ratio was 32.56%, and gross margin was 46.12%, down 2.44 percentage points from the same period last year. Diluted earnings per share were 0.15 yuan, down 34.02% year-on-year. The number of shareholders was 338,500, and the top ten shareholders held 58.63% of total share capital.
Jiemian·22dRead more →
300015.CS

Aier Eye Hospital Invests 200 Million Yuan in Venture Fund, Accounting for 28.49% of Capital

Aier Eye Hospital announced it will invest 200 million yuan of its own funds in Gongqingcheng Jianchi Shengqi Venture Capital Partnership, a limited partnership. The fund has a total committed capital of 702 million yuan, with the company contributing 28.49 percent. The dedicated fund will primarily invest in a single target equity. In the first quarter of 2026, Aier Eye Hospital achieved revenue of 6.396 billion yuan and net profit attributable to the parent company of 1.181 billion yuan.
财中社·50dRead more →
300015.CS

Aier Eye Hospital's Actual Controller Chen Bang Has Pledged 19.53% of His Stake

Aier Eye Hospital's actual controller Chen Bang has cumulatively pledged 282 million shares, accounting for 19.53% of his total holdings. According to a company announcement on July 31, Chen Bang pledged 160 million shares, representing 11.08% of his holdings and 1.72% of the company's total share capital. At the same time, he released the pledge on 139 million shares, representing 9.63% of his holdings and 1.49% of the company's total share capital. In the first quarter of 2026, Aier Eye Hospital achieved revenue of 6.396 billion yuan and a net profit attributable to the parent company of 1.181 billion yuan.
财中社·50dRead more →
300015.CS3

ZEISS Medical Technology and Aier Eye Hospital Group sign deal for 25 VISUMAX 800 lasers

ZEISS Medical Technology and Aier Eye Hospital Group have signed a strategic agreement for the purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers. The signing ceremony took place on June 12 at Aier Eye Hospital Group's headquarters in Changsha, Hunan Province. The 25 systems will be progressively deployed across Aier's domestic and international networks starting later in 2026. The partnership aims to enhance patient care through technological innovation and bring precise refractive surgery to patients worldwide. Aier Eye Hospital will become the ophthalmic institution with the largest installed base of ZEISS VISUMAX 800 systems globally, the most ZEISS SMILE pro-certified surgeons, and the highest number of KLEx procedures performed with ZEISS SMILE pro in China.
PR Newswire·93dRead more →